(Q46640139)

English

Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.

scientific article published on 17 April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18418592

Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT. (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18418592

1 reference

based on heuristic

inferred from title

author name string

Kazuhiro Kitajima

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18418592

Koji Murakami

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18418592

Erena Yamasaki

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18418592

Yasushi Domeki

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18418592

Yasushi Kaji

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18418592

Ichio Fukasawa

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18418592

Noriyuki Inaba

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18418592

Narufumi Suganuma

8

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18418592

Kazuro Sugimura

9

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18418592

publication date

17 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18418592

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18418592

35

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18418592

8

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18418592

1439-1448

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18418592

https://scigraph.springernature.com/pub.10.1007/s00259-008-0776-3

0 references

Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0776-3

21 January 2018

Role of CT in the management of recurrent ovarian cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0776-3

21 January 2018

Ovarian cancer: staging with CT and MR imaging.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-008-0776-3

21 January 2018

Low dose non-enhanced CT versus standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning in non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer of the ovary

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical role of FDG PET in evaluation of cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-D-glucose positron emission tomography.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Computed tomography and second-look surgery in ovarian cancer patients. Correlation, actual role and limitations of CT scan

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of CA 125 in follow-up of ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Integrated FDG PET/CT in patients with persistent ovarian cancer: correlation with histologic findings.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thin-section CT follow-up of metastatic ovarian carcinoma correlation with levels of CA-125 marker and clinical history

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlations of serum CA125 level and computerized tomography (CT) imaging with laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PET-CT vs. CT alone in ovarian cancer recurrence

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PET/CT in lymphoma: prospective study of enhanced full-dose PET/CT versus unenhanced low-dose PET/CT.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Usefulness of whole body positron emission tomography (PET) with 18F-fluoro-2-deoxyglucose (FDG) to detect recurrent ovarian cancer based on asymptomatically elevated serum levels of tumor marker

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of integrated whole-body PET/CT in the detection of recurrent ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Staging of advanced ovarian cancer: comparison of imaging modalities--report from the Radiological Diagnostic Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytoreductive surgery for advanced stages of ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-small cell lung cancer: dual-modality PET/CT in preoperative staging

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multidetector CT of Peritoneal Carcinomatosis from Ovarian Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective evaluation of contrast-enhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A combined PET/CT scanner for clinical oncology.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer statistics, 2001

1 reference

https://pubmed.ncbi.nlm.nih.gov/18418592

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-008-0776-3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18418592

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18418592

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46640139&oldid=2198161133"